Disease progression and resource utilization in treated relapse/refractory multiple myeloma in Spain (PREMIERE) First published 18/08/2015 Last updated 31/03/2024 EU PAS number:EUPAS10691 Study Finalised
OXON Epidemiology Spain United Kingdom First published:06/12/2010 Last updated 15/03/2024 Institution Laboratory/Research/Testing facility Non-Pharmaceutical company ENCePP partner
Nawab Qizilbash MBChB MRCP(UK) BSc MSc DPhil(Oxon.) nawab.qizilbash@oxonepi.comStudy contactnawab.qizilbash@oxonepi.com